Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
13.03
-1.92 (-12.84%)
At close: Apr 28, 2026, 4:00 PM EDT
13.27
+0.24 (1.84%)
After-hours: Apr 28, 2026, 7:54 PM EDT
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $2.47 billion as of April 28, 2026. Its market cap has increased by 555.10% in one year.
Market Cap
2.47B
Enterprise Value
1.94B
1-Year Change
555.10%
Ranking
Category
Stock Price
$13.03
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has decreased from $3.03B to $2.47B, a decrease of -18.76%. That is a compound annual growth rate of -3.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 2.83B | 92.91% |
| Dec 31, 2025 | 1.47B | 112.63% |
| Dec 31, 2024 | 689.62M | -49.19% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Soleno Therapeutics | 2.73B |
| Vera Therapeutics | 2.72B |
| Celldex Therapeutics | 2.66B |
| Immunome | 2.63B |
| Tarsus Pharmaceuticals | 2.63B |
| Disc Medicine | 2.63B |
| Enliven Therapeutics | 2.62B |
| IDEAYA Biosciences | 2.58B |